CytRx to Present at Rodman & Renshaw 12th Annual Healthcare Conference

Show Health and Fitness Publications

Thu, September 16, 2010

[ Thu, Sep 16th 2010 ] - Market Wire

Osiris Therapeutics to Present at UBS Global Life Sciences Conference

[ Thu, Sep 16th 2010 ] - Market Wire

Community Health Systems Announces New 4 Million Share Open Market Share Repurchase

[ Thu, Sep 16th 2010 ] - Market Wire

Aetna Signs Contract Extension with University of Pennsylvania Health System

[ Thu, Sep 16th 2010 ] - Market Wire

CYTOGENIX, INC. Schedules Shareholder's Conference Call on September 22nd

[ Thu, Sep 16th 2010 ] - Market Wire

Abiomed Showcases Impella® Technology at TCT 201 .. eakfast Series Featuring USpella and Case Reviews

[ Thu, Sep 16th 2010 ] - Market Wire

Healthways Announces Achievements in Medicare Health Support; Other Seniorsa? Programs

[ Thu, Sep 16th 2010 ] - Market Wire

Medtronic Receives European CE Mark Approval for .. Brain Stimulation Therapy for Refractory Epilepsy

[ Thu, Sep 16th 2010 ] - Market Wire

Cellular Dynamics International, ACEA Biosciences .. Cooperate to Evaluate iCell Cardiomyocytes on the

[ Thu, Sep 16th 2010 ] - Market Wire

NPS Pharmaceuticals Announces Pricing of Public Offering of Common Stock

[ Thu, Sep 16th 2010 ] - Market Wire

ImmunoCellular Therapeutics Selects Averion Inter .. onal Corp. to Conduct Phase II Glioblastoma Study

[ Thu, Sep 16th 2010 ] - Market Wire

Akorn Announces Launch of Erythromycin Ophthalmic Ointment USP 1 g

[ Thu, Sep 16th 2010 ] - Market Wire

GTx Announces Corporate Presentation at the UBS Global Life Sciences Conference

[ Thu, Sep 16th 2010 ] - Market Wire

Alkermes Stock Trading Halted Today

[ Thu, Sep 16th 2010 ] - Market Wire

BioCryst Reports Positive Results From A Phase 2 .. 8 Combined with Allopurinol in Patients with Gout

Wed, September 15, 2010

[ Wed, Sep 15th 2010 ] - Market Wire

Gileads HIV-Einzeltablette, das aQuada-Prparat, z .. 8-wchiger Phase-II-Studie hohe virale Suppression

[ Wed, Sep 15th 2010 ] - Market Wire

Covidien maakt hoogtepunten beleggersvergadering bekend

[ Wed, Sep 15th 2010 ] - Market Wire

Qtrax Beta Available in India

[ Wed, Sep 15th 2010 ] - Market Wire

Covidien Anuncia Destaques da Assembl©ia de Investidores

[ Wed, Sep 15th 2010 ] - Market Wire

Forest Laboratories, Inc. Finalizes Previously Di .. vernment Investigations and Related Civil Qui Tam

[ Wed, Sep 15th 2010 ] - Market Wire

Crozer-Keystone Health System Joins Aetna Better Health Network

[ Wed, Sep 15th 2010 ] - Market Wire

Bond Labs Expands Resurrection(TM) into the Atlanta and Savannah Markets

[ Wed, Sep 15th 2010 ] - Market Wire

BioCryst to Present Peramivir Data at the 50th Annual ICAAC Meeting

[ Wed, Sep 15th 2010 ] - Market Wire

Celgene Corporation to Present at the UBS 2010 Global Life Sciences Conference

[ Wed, Sep 15th 2010 ] - Market Wire

Medical Action Industries to Present in the 2010 UBS Global Life Sciences Conference

[ Wed, Sep 15th 2010 ] - Market Wire

ArthroCare to Present at UBS Global Life Sciences Conference

[ Wed, Sep 15th 2010 ] - Market Wire

BioCryst Reports Results from Two Forodesine Oncology Studies

[ Wed, Sep 15th 2010 ] - Market Wire

SuperGen to Present at UBS Global Life Sciences Conference on September 22nd

[ Wed, Sep 15th 2010 ] - Market Wire

Four Rivers Announces Licensure of STT Technology .. Gain, Reduction of Overhead Costs and Future Prof

Tue, September 14, 2010

[ Tue, Sep 14th 2010 ] - Market Wire

Law Offices of Howard G. Smith Announces Investig .. n On Behalf of Shareholders of ZymoGenetics, Inc.

[ Tue, Sep 14th 2010 ] - Market Wire

Human Genome Sciences Invites Investors to Listen .. entation at Stifel Nicolaus Healthcare Conference

[ Tue, Sep 14th 2010 ] - Market Wire

The Briscoe Law Firm and Powers Taylor, LLP Inves .. Fiduciary Duties by the Officers and Directors of

[ Tue, Sep 14th 2010 ] - Market Wire

Alexion to Present at the UBS Global Life Sciences Conference

[ Tue, Sep 14th 2010 ] - Market Wire

Alkermes Announces Posting of Briefing Documents .. ttee Meeting for VIVITROL® for Opioid Dependence

[ Tue, Sep 14th 2010 ] - Market Wire

Guided Therapeutics Completes $3 Million Financing

[ Tue, Sep 14th 2010 ] - Market Wire

Somaxon Pharmaceuticals to Present at the UBS Global Life Sciences Conference

[ Tue, Sep 14th 2010 ] - Market Wire

Derma Sciences to Complete Enrollment in DSC127 Phase 2 Wound Healing Trial This Month

[ Tue, Sep 14th 2010 ] - Market Wire

Synergy Pharmaceuticals to Present at Roche Colorado Corporation Peptide Symposium 2010

[ Tue, Sep 14th 2010 ] - Market Wire

Vortrag von Synergy Pharmaceuticals auf dem Roche Colorado Corporation Peptide Symposium 2010

[ Tue, Sep 14th 2010 ] - Market Wire

CENTRIC HEALTH APPOINTS DR. PAUL GAMBLE TO BOARD OF DIRECTORS

[ Tue, Sep 14th 2010 ] - Market Wire

AngioDynamics Strengthens Executive Team with Key Appointments

[ Tue, Sep 14th 2010 ] - Market Wire

Inspire Announces Webcasts of Presentations at th .. nference and the JMP Securities Healthcare Confer

Mon, September 13, 2010

[ Mon, Sep 13th 2010 ] - Market Wire

Il regime quadruplo a monosomministrazione giorna .. 'HIV di Gilead consente il mantenimento di una so

[ Mon, Sep 13th 2010 ] - Market Wire

A New Audio Interview Featuring Frank Mir, Director of Suffer Apparel, is Now at SmallCapVoice.com

[ Mon, Sep 13th 2010 ] - Market Wire

Allos Therapeutics to Present at Upcoming Investor Conferences

[ Mon, Sep 13th 2010 ] - Market Wire

Biomagnetics Moves Zhuhai Oil Energy Acquisition .. t Phase - Expects Closing During CEO Trip to Chin

[ Mon, Sep 13th 2010 ] - Market Wire

PerkinElmer to Present at UBS Global Life Science Conference

[ Mon, Sep 13th 2010 ] - Market Wire

ARIAD Announces Initiation of Ponatinib (AP24534) .. -Resistant or Intolerant Chronic Myeloid Leukemia

[ Mon, Sep 13th 2010 ] - Market Wire

Pro-Pharmaceuticals Collaborates with Numoda to M .. l Trial to Increase Speed-to-Market for DAVANAT®

[ Mon, Sep 13th 2010 ] - Market Wire

Geron Obtains Exclusive License for Deriving Cart .. Embryonic Stem Cells from University of Edinburgh

[ Mon, Sep 13th 2010 ] - Market Wire

Forest Responds to FDA Complete Response Letter for Roflumilast

[ Mon, Sep 13th 2010 ] - Market Wire

UnitedHealth Group Named to Dow Jones Sustainabil .. erica and World Indices for 12th Consecutive Year

[ Mon, Sep 13th 2010 ] - Market Wire

XenoPort Announces Plans for Phase 3 Development of Arbaclofen Placarbil for Spasticity

[ Mon, Sep 13th 2010 ] - Market Wire

LabCorp Enters into Definitive Agreement to Acquire Genzyme Genetics

[ Mon, Sep 13th 2010 ] - Market Wire

Genoptix Announces Participation at the 2010 UBS Global Life Sciences Conference

Sun, September 12, 2010

[ Sun, Sep 12th 2010 ] - Market Wire

Santarus Adds Two Novel Biologic Drug Candidates to Pipeline

Fri, September 10, 2010

[ Fri, Sep 10th 2010 ] - Market Wire

Seattle Genetics to Host Conference Call and Webc .. Discuss Top-line Data from Lintuzumab (SGN-33) Ph

[ Fri, Sep 10th 2010 ] - Market Wire

ISS Recommends That Response Genetics Shareholder .. Gold Proxy Card to Re-Elect Experienced Directors

[ Fri, Sep 10th 2010 ] - Market Wire

Fitch Affirms CareFusion Corporation's Ratings at 'BBB'; Outlook Stable

[ Fri, Sep 10th 2010 ] - Market Wire

Advanced Cell Technology to Present at the 12th A .. ual Rodman & Renshaw Global Investment Conference

[ Fri, Sep 10th 2010 ] - Market Wire

Orthovita to Present at the UBS Global Life Sciences Conference

[ Fri, Sep 10th 2010 ] - Market Wire

Medtronic Releases 2010 Corporate Citizenship Report

[ Fri, Sep 10th 2010 ] - Market Wire

Teva to Present at the Morgan Stanley Global Healthcare Conference

[ Fri, Sep 10th 2010 ] - Market Wire

Cubist Pharmaceuticalsa? Antibiotic Programs Featured in 47 Presentations at 50th ICAAC

[ Fri, Sep 10th 2010 ] - Market Wire

ArQule, Inc. to Present at Stifel Nicolaus and UBS Conferences

[ Fri, Sep 10th 2010 ] - Market Wire

PerkinElmer to Present at Stifel Nicolaus Healthcare Conference

[ Fri, Sep 10th 2010 ] - Market Wire

Orthofix International to Participate inStifel Nicolaus 2010 Healthcare Conference

[ Fri, Sep 10th 2010 ] - Market Wire

Pro-Pharmaceuticalsa? Presentation at Rodman and .. l Global Investment Conference to Be Webcast Live

[ Fri, Sep 10th 2010 ] - Market Wire

Bioniche Reports Fiscal 2010 Year-End Results

Thu, September 9, 2010

[ Thu, Sep 09th 2010 ] - Market Wire

Amedisys to Present at Two Upcoming Conferences

[ Thu, Sep 09th 2010 ] - Market Wire

Tenet Management to Speak at the Morgan Stanley Global Healthcare Conference on September 14, 2010

[ Thu, Sep 09th 2010 ] - Market Wire

Cohen Milstein Sellers & Toll PLLC Announces Class Action Lawsuit against Almost Family, Inc.

[ Thu, Sep 09th 2010 ] - Market Wire

Helicos BioSciences Files Patent Infringement Lawsuit Against Pacific Biosciences

[ Thu, Sep 09th 2010 ] - Market Wire

Santarus Licenses Novel Type 2 Diabetes Drug CYCLOSET

[ Thu, Sep 09th 2010 ] - Market Wire

CIGNA Announces Appearance at the Morgan Stanley Global Healthcare Conference

[ Thu, Sep 09th 2010 ] - Market Wire

Elan Statement Regarding Shareholder Call

[ Thu, Sep 09th 2010 ] - Market Wire

Media Advisory - Oncolytics Biotech(R) Inc. to Pr .. an &; Renshaw Annual Global Investment Conference

[ Thu, Sep 09th 2010 ] - Market Wire

AngioDynamics to Participate At Upcoming Investor Conferences

[ Thu, Sep 09th 2010 ] - Market Wire

CombinatoRx Changes Company Name to Zalicus Inc.

[ Thu, Sep 09th 2010 ] - Market Wire

Salix Pharmaceuticals to Present at Stifel Nicolaus Conference

[ Thu, Sep 09th 2010 ] - Market Wire

Schiff Nutrition International, Inc. to Present a .. ing's 8th Best Ideas Conference on September 16th

[ Thu, Sep 09th 2010 ] - Market Wire

Schiff Nutrition International, Inc. Announces Timing of Fiscal 2011 First Quarter Results

Wed, September 8, 2010

[ Wed, Sep 08th 2010 ] - Market Wire

YM BioSciences announces positive results from CY .. se I study published in British Journal of Cancer

[ Wed, Sep 08th 2010 ] - Market Wire

Hi-Tech Pharmacal Reports Sales of $40.4 Million .. EPS of $0.67 for the Quarter Ended July 31, 2010

[ Wed, Sep 08th 2010 ] - Market Wire

Inspire Announces Webcast of Presentation at Stifel Nicolaus Healthcare Conference

[ Wed, Sep 08th 2010 ] - Market Wire

The Shuman Law Firm Announces the Filing of a Cla .. on Lawsuit Against SciClone Pharmaceuticals, Inc.

[ Wed, Sep 08th 2010 ] - Market Wire

LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference

[ Wed, Sep 08th 2010 ] - Market Wire

Kindred Healthcare to Participate in the Stifel Nicolaus 2010 Healthcare Conference

[ Wed, Sep 08th 2010 ] - Market Wire

AngioDynamics Reports Preliminary Fiscal 2011 First Quarter Results

[ Wed, Sep 08th 2010 ] - Market Wire

FDA Advisory Committee Recommends Approval of For .. e Fosamil for the Treatment of Community Acquired

[ Wed, Sep 08th 2010 ] - Market Wire

AGA Medical to Present at the Baird 2010 Health Care Conference

[ Wed, Sep 08th 2010 ] - Market Wire

PPD Establishes Network of Sites for Conducting Phase I Trials in Patients

[ Wed, Sep 08th 2010 ] - Market Wire

Health Management Associates, Inc. to Present at the Morgan Stanley Global Healthcare Conference

[ Wed, Sep 08th 2010 ] - Market Wire

65% of People Whose Prior Treatment for Hepatitis .. SVR (Viral Cure) with Telaprevir-Based Therapy in

[ Wed, Sep 08th 2010 ] - Market Wire

Resurrectiona" Showcased to NYC at the Attica 2 Year Anniversary Party

Tue, September 7, 2010

[ Tue, Sep 07th 2010 ] - Market Wire

Court Denies Sandoz/Momenta's Summary Judgment of Invalidity in Copaxone® Litigation

[ Tue, Sep 07th 2010 ] - Market Wire

Array BioPharma to Present at the Rodman & Rensha .. nce and the Stifel Nicolaus Healthcare Conference

[ Tue, Sep 07th 2010 ] - Market Wire

La Jolla Pharmaceutical Company Provides Update o .. ch for Clinical Products to In-License or Acquire

[ Tue, Sep 07th 2010 ] - Market Wire

Orthofix International to Participate in Morgan Stanley Unplugged Healthcare Conference

[ Tue, Sep 07th 2010 ] - Market Wire

BioSante Pharmaceuticals, Inc. to Present at the Rodman & Renshaw Healthcare Conference

[ Tue, Sep 07th 2010 ] - Market Wire

Health Net Federal Services Meets Target Enrollme .. Chronic Obstructive Pulmonary Disease Management

[ Tue, Sep 07th 2010 ] - Market Wire

CytRx Initiates Phase 2 Clinical Trial with Bafetinib in Advanced Prostate Cancer

[ Tue, Sep 07th 2010 ] - Market Wire

Somaxon Pharmaceuticals Announces Commercial Availability of Silenor

[ Tue, Sep 07th 2010 ] - Market Wire

Transdel Pharmaceuticals to Present at Rodman & Renshaw 12th Annual Healthcare Conference

[ Tue, Sep 07th 2010 ] - Market Wire

Response Genetics, Inc. to Present at the Rodman & Renshaw 12th Annual Healthcare Conference

[ Tue, Sep 07th 2010 ] - Market Wire

Rosetta Genomics to Present at the Rodman & Renshaw 12th Annual Global Investment Conference

[ Tue, Sep 07th 2010 ] - Market Wire

BioDelivery Sciences Adds New Executive to Lead Business and Strategic Development

[ Tue, Sep 07th 2010 ] - Market Wire

SuperGen to Present at Rodman & Renshaw Annual Healthcare Conference on September 13th

Sat, September 4, 2010

[ Sat, Sep 04th 2010 ] - Market Wire

Herbert A. Fritsche, Ph.D., anteriormente profeso .. on Cancer Center, se incorpora a Health Discovery

[ Sat, Sep 04th 2010 ] - Market Wire

Transdel Pharmaceuticals

[ Sat, Sep 04th 2010 ] - Market Wire

Curis to Present at the Rodman & Renshaw 12th Annual Healthcare Conference

[ Sat, Sep 04th 2010 ] - Market Wire

Wright Medical Group, Inc. to Participate in Upcoming September 2010 Healthcare Conferences

[ Sat, Sep 04th 2010 ] - Market Wire

Aetna Reminds Members Affected by Hurricane Earl Where to Call for Help

[ Sat, Sep 04th 2010 ] - Market Wire

Herbert A. Fritsche, Ph.D., ehemaliger Professor .. nderson Cancer Center tritt Health Discovery Corp

[ Sat, Sep 04th 2010 ] - Market Wire

UnitedHealth Group to Support Members Affected by Hurricane Earl

Fri, September 3, 2010

[ Fri, Sep 03rd 2010 ] - Market Wire

Herbert A. Fritsche, Ph.D., cientista e antigo pr .. o do Anderson Cancer Center, junta-se a Health Di

[ Fri, Sep 03rd 2010 ] - Market Wire

Gilead Sciences presenta alla?Agenzia Europea per .. torizzazione per la?immissione in commercio delle

[ Fri, Sep 03rd 2010 ] - Market Wire

ImmunoCellular Therapeutics Issues Letter to Shareholders

[ Fri, Sep 03rd 2010 ] - Market Wire

Life Technologies to Present at the UBS Global Life Sciences Conference

[ Fri, Sep 03rd 2010 ] - Market Wire

American Learning Corporation to Appeal Nasdaq Delisting Notice

[ Fri, Sep 03rd 2010 ] - Market Wire

KCI?????LifeCella" ???Novadaq Technologies????????????SPY®????????????

[ Fri, Sep 03rd 2010 ] - Market Wire

/C O R R E C T I O N - Mindray Medical International Limited /

[ Fri, Sep 03rd 2010 ] - Market Wire

MDS to Release Third Quarter 2010 Financial Results

[ Fri, Sep 03rd 2010 ] - Market Wire

Tibotec Pharmaceuticals Seeks European Marketing .. r Investigational Once-Daily HIV Treatment TMC278

[ Fri, Sep 03rd 2010 ] - Market Wire

Medisafe 1 Technologies Clarifies the PR Issued o .. ividend, as a Forward Split of 5-1 in the Form of

[ Fri, Sep 03rd 2010 ] - Market Wire

Gilead Sciences Submits European Marketing Applic .. blet Regimen of Truvada® and TMC278 for the Trea

[ Fri, Sep 03rd 2010 ] - Market Wire

Alcon Launches AcrySof® IQ ReSTOR® Toric Intraocular Lens Outside the United States

[ Fri, Sep 03rd 2010 ] - Market Wire

Gilead Sciences dient aanvraag in voor Europese m .. van ©©n tablet per dag van Truvada en TMC278 t

Thu, September 2, 2010

[ Thu, Sep 02nd 2010 ] - Market Wire

Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Allergan, Inc.

[ Thu, Sep 02nd 2010 ] - Market Wire

BRINAVESSa" (vernakalant) per infusione approvato .. conversione rapida della fibrillazione atriale di

[ Thu, Sep 02nd 2010 ] - Market Wire

BioDelivery Sciences Announces Positive Meeting w .. eamlined ONSOLIS REMS with Broadened Distribution

[ Thu, Sep 02nd 2010 ] - Market Wire

KCIa?s LifeCell Corporation en Novadaq Technologi .. verkoop- en marketingovereenkomst voor exclusieve

[ Thu, Sep 02nd 2010 ] - Market Wire

Cardiome Achieves $30 Million Milestone

[ Thu, Sep 02nd 2010 ] - Market Wire

Oncolytics Biotech(R) Inc. Announces Randomized P .. to be Conducted by the Gynecologic Oncology Group

[ Thu, Sep 02nd 2010 ] - Market Wire

Rosetta Genomics to Host Second Quarter 2010 Conference Call on Wednesday, September 8, 2010

[ Thu, Sep 02nd 2010 ] - Market Wire

MedPro Safety Products Completes Royalty Monetization Transaction

[ Thu, Sep 02nd 2010 ] - Market Wire

ImmunoGen, Inc. Announces Webcast of Presentations at Multiple Investor Conferences in September

[ Thu, Sep 02nd 2010 ] - Market Wire

AVEO Pharmaceuticals, Inc. to Present at Several Upcoming Investment Conferences

[ Thu, Sep 02nd 2010 ] - Market Wire

Gilead geeft update over aandelenterugkoop van 5 miljard dollar

[ Thu, Sep 02nd 2010 ] - Market Wire

Transdel Pharmaceuticals Presents Phase 3 Study D .. sdel® at World Pain Congress in Montreal, Canada

[ Thu, Sep 02nd 2010 ] - Market Wire

La divisione di KCI LifeCella" Corporation e Nova .. contratto di vendita e marketing per la distribu

Wed, September 1, 2010

[ Wed, Sep 01st 2010 ] - Market Wire

Gilead presenta ltimos datos sobre programa de recompra de acciones por valor de $5.000 millones

[ Wed, Sep 01st 2010 ] - Market Wire

Health Net Strives to Exceed $75,000 Goal Through Annual Golf Classic Despite Hard Economic Times

[ Wed, Sep 01st 2010 ] - Market Wire

Navigant Capital Advisors, LLC Serves as Financia .. Health Systems, Inc. in Its $156.8 Million Sale t

[ Wed, Sep 01st 2010 ] - Market Wire

Amerigroup Launches 24/7 Nurse Pilot Program: A First for Tennessee

[ Wed, Sep 01st 2010 ] - Market Wire

Amerigroup Launches 24/7 Nurse Pilot Program: A First for Maryland

[ Wed, Sep 01st 2010 ] - Market Wire

Inhibitex Successfully Completes Phase 1a Trial of INX-189

[ Wed, Sep 01st 2010 ] - Market Wire

Covidien Announces Investor Meeting Agenda

[ Wed, Sep 01st 2010 ] - Market Wire

Covidien annuncia il programma della riunione degli investitori

[ Wed, Sep 01st 2010 ] - Market Wire

Covidien gibt Tagesordnung seiner Investorenversammlung bekannt

[ Wed, Sep 01st 2010 ] - Market Wire

Covidien divulga programa da reunio com investidores

[ Wed, Sep 01st 2010 ] - Market Wire

Archimedes Pharma Receives European Marketing Aut .. (R) for the Treatment of Breakthrough Cancer Pain

[ Wed, Sep 01st 2010 ] - Market Wire

Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer

[ Wed, Sep 01st 2010 ] - Market Wire

Emergent BioSolutions Awarded NIAID Contract That .. to Over $58 Million for Advanced Development of T

Tue, August 31, 2010

[ Tue, Aug 31st 2010 ] - Market Wire

Proskauer Represents Sumner Regional Health Syste .. in Its $156.8 Million Sale to LifePoint Hospitals

[ Tue, Aug 31st 2010 ] - Market Wire

New 2010 ESC Guidelines for Percutaneous Coronary .. rtance of FFR in Treatment of Coronary Artery Dis

[ Tue, Aug 31st 2010 ] - Market Wire

Allergan, Inc. Receives FDA Approval for LUMIGAN� .. Indicated for the Reduction of Elevated Intraocul

[ Tue, Aug 31st 2010 ] - Market Wire

Teleflex to Present at the Stifel Nicolaus 2010 Healthcare Conference

[ Tue, Aug 31st 2010 ] - Market Wire

Quidel Announces FDA Clearance of Its RapidVue® hCG Pregnancy Lateral Flow Diagnostic Test

[ Tue, Aug 31st 2010 ] - Market Wire

Tenet Announces Completion of Cash Tender Offer for 7.375% Senior Notes due 2013

[ Tue, Aug 31st 2010 ] - Market Wire

Humana Awarded Contracts for Puerto Rico Medicaid Program

[ Tue, Aug 31st 2010 ] - Market Wire

Bernstein Liebhard LLP Announces Investigation on Behalf of Shareholders of Genzyme Corporation

[ Tue, Aug 31st 2010 ] - Market Wire

PacificHealth Laboratories Promotes Fred Duffner, Current President, to CEO and President

[ Tue, Aug 31st 2010 ] - Market Wire

Progenics Pharmaceuticals to Present Preclinical .. nal Antibodies Against C. difficile at 2010 ICAAC

[ Tue, Aug 31st 2010 ] - Market Wire

American CareSource Holdings Adds Benefit Administrative Systems to Client Portfolio

[ Tue, Aug 31st 2010 ] - Market Wire

Orthofix International Establishes New $300 Million Credit Facility

[ Tue, Aug 31st 2010 ] - Market Wire

Affymax® Announces Upcoming Webcasts and Conference Participation

Mon, August 30, 2010

[ Mon, Aug 30th 2010 ] - Market Wire

RehabCare to Present at the Stifel Nicolaus Healthcare Conference 2010

[ Mon, Aug 30th 2010 ] - Market Wire

Elan Corporation plc Announces Commencement of As .. to $186,000,000 of 8 7/8% Senior Fixed Rate Note

[ Mon, Aug 30th 2010 ] - Market Wire

Teleflex to Present at the Morgan Stanley Global Healthcare Conference

[ Mon, Aug 30th 2010 ] - Market Wire

Pre and Post-Operative Use of Caldolor® (Ibuprof .. duces Pain and Opioid Use in Newly Published Stud

[ Mon, Aug 30th 2010 ] - Market Wire

Covidien voltooit verkoop van productlijn voor slaaptherapie

[ Mon, Aug 30th 2010 ] - Market Wire

Biomagnetics Announces LOI to Acquire Lanzhou New .. TD Fourth Chinese Asset Targeted at $1.50 BMGP Sh

[ Mon, Aug 30th 2010 ] - Market Wire

BEMA Buprenorphine Phase 2 Study Results Selected for Presentation at Pain Week 2010

[ Mon, Aug 30th 2010 ] - Market Wire

Covidien Completes Sale of Sleep Therapy Product Line

[ Mon, Aug 30th 2010 ] - Market Wire

Covidien perfeziona la vendita della linea di prodotti per la terapia del sonno

[ Mon, Aug 30th 2010 ] - Market Wire

Covidien cl'ture la vente de sa ligne de produits de th©rapie du sommeil

[ Mon, Aug 30th 2010 ] - Market Wire

Covidien schliet Verkauf der Produktlinie fr Schlaftherapien ab

[ Mon, Aug 30th 2010 ] - Market Wire

Covidien Completes Sale of Specialty Chemicals Business

[ Mon, Aug 30th 2010 ] - Market Wire

PURATEIN(R) AND SUPERTEIN(TM) GRAS NOTIFIED - U.S .. ISSUES NO OBJECTION LETTER ON GRAS STATUS OF PUR

Sun, August 29, 2010

[ Sun, Aug 29th 2010 ] - Market Wire

Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients

Fri, August 27, 2010

[ Fri, Aug 27th 2010 ] - Market Wire

Aetna Completes $750 Million, 10-Year Bond Offering

[ Fri, Aug 27th 2010 ] - Market Wire

Medical Action Industries Inc. Completes Acquisition of AVID Medical, Inc.

[ Fri, Aug 27th 2010 ] - Market Wire

Zynex Announces New ChiefFinancial Officer

[ Fri, Aug 27th 2010 ] - Market Wire

Experienced Financial Executive, Peter Donato, Joins Hythiam as CFO

[ Fri, Aug 27th 2010 ] - Market Wire

?????????????????????

[ Fri, Aug 27th 2010 ] - Market Wire

HealthSpring, Inc. to Acquire Bravo Health, Inc.

[ Fri, Aug 27th 2010 ] - Market Wire

Genentech Receives Refuse to File Letter from FDA for T-DM1

Thu, August 26, 2010

[ Thu, Aug 26th 2010 ] - Market Wire

Novartis completa la compra a Nestl© de intereses mayoritarios en Alcon

[ Thu, Aug 26th 2010 ] - Market Wire

Novartis erwirbt Aktienmehrheit an Alcon von Nestl©

[ Thu, Aug 26th 2010 ] - Market Wire

Novartis conclui compra de participao majoritria da Nestl© na Alcon

[ Thu, Aug 26th 2010 ] - Market Wire

RehabCare to Present at the Morgan Stanley Global Healthcare Conference

[ Thu, Aug 26th 2010 ] - Market Wire

Spectral Molecular Imaging, Inc. Announces Accele .. its Early Melanoma Detection Product SkinSpecta"

[ Thu, Aug 26th 2010 ] - Market Wire

Health Net, Inc. Mourns the Death of Thomas T. Farley, a Member of Its Board of Directors

[ Thu, Aug 26th 2010 ] - Market Wire

American HomePatient Announces Five Business Day .. lf-Tender Offer and Modification of 90% Condition

[ Thu, Aug 26th 2010 ] - Market Wire

Medtronic reoit de Sant© Canada la?homologation .. ?ablation de la fibrillation auriculaire par radi

[ Thu, Aug 26th 2010 ] - Market Wire

Medtronic Receives Health Canada Approval for the .. ofrequency Ablation Tools for Atrial Fibrillation

[ Thu, Aug 26th 2010 ] - Market Wire

International Stem Cell Corporation Not Adversely Affected by Stem Cell Research Funding Ban

[ Thu, Aug 26th 2010 ] - Market Wire

Celgene Corporation Announces Appointment of Jacq .. Senior Vice President and Chief Financial Officer

[ Thu, Aug 26th 2010 ] - Market Wire

Novartis voltooit aankoop meerderheidsbelang Alcon van Nestl©

[ Thu, Aug 26th 2010 ] - Market Wire

Novartis completa acquisto da Nestl© di interesse di maggioranza su Alcon

CytRx to Present at Rodman & Renshaw 12th Annual Healthcare Conference

_{//health-fitness.news-articles.net/content/2010/ .. n-renshaw-12th-annual-healthcare-conference.html}
^{Published in Health and Fitness on Wednesday, September 8th 2010 at 6:51 GMT by Market Wire}

LOS ANGELES--([ BUSINESS WIRE ])--CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical company specializing in oncology, today announced that President and Chief Executive Officer Steven A. Kriegsman and Chief Medical Officer Daniel Levitt, MD, Ph.D., will be presenting at the 12^th Annual Rodman & Renshaw Healthcare Conference on Tuesday, September 14, at 9:35 a.m. Eastern time (6:35 a.m. Pacific time). The conference is being held at the New York Palace Hotel.

The CytRx presentation will address actions to advance the clinical development of the Companya�s high-value oncology development pipeline, including a discussion of the recently initiated Phase 2 clinical trials to evaluate the efficacy and safety of bafetinib in patients with advanced prostate cancer and high-risk B-cell chronic lymphocytic leukemia, and plans to initiate up to four additional oncology clinical trials.

A live webcast of the presentation will be available at [ http://www.cytrx.com ] and a webcast replay will be archived on the Company's website for 90 days.

About CytRx Corporation

CytRx Corporation is a biopharmaceutical research and development oncology company engaged in the development of high-value human therapeutics. The CytRx oncology pipeline includes three programs in clinical development for cancer indications: bafetinib, tamibarotene and INNO-206. The Company is evaluating bafetinib in the ENABLE Phase 2 clinical trial in high-risk B-cell chronic lymphocytic leukemia (B-CLL) and the PROACT Phase 2 clinical trial in advanced prostate cancer, and plans to begin a Phase 1 trial in brain cancer. CytRx has announced plans to initiate up to three Phase 2 clinical trials with its oncology candidate INNO-206 as a treatment for pancreatic cancer, gastric cancer and soft tissue sarcomas. In addition, CytRx is developing two drug candidates based on its industry-leading molecular chaperone technology, which aims to repair or degrade misfolded proteins associated with disease. CytRx also maintains a 17% equity interest in publicly traded RXi Pharmaceuticals, Inc. (NASDAQ: RXII). For more information on the Company, visit [ http://www.cytrx.com ].

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire